1、 KIM S J,ROH J,BAEK J H,et al. Risk of malignancy according to sub-classification of the atypia of undetermined significance or follicular lesion of undetermined significance (AUS/FLUS) category in the Bethesda system for reporting thyroid cytopathology [J]. Cytopathology,2017,28 (1):65-73. KIM S J,ROH J,BAEK J H,et al. Risk of malignancy according to sub-classification of the atypia of undetermined significance or follicular lesion of undetermined significance (AUS/FLUS) category in the Bethesda system for reporting thyroid cytopathology [J]. Cytopathology,2017,28 (1):65-73.
2、 OLSON M T,CLARK D P,EROZAN Y S,et al. Spectrum of risk of malignancy in subcategories of “atypia of undetermined significance” [J]. Acta Cytol,2011,55 (6):518-525. OLSON M T,CLARK D P,EROZAN Y S,et al. Spectrum of risk of malignancy in subcategories of “atypia of undetermined significance” [J]. Acta Cytol,2011,55 (6):518-525.
3、 HYEON J,AHN S,SHIN J H,et al. The Prediction of malignant risk in the category “atypia of undetermined significance/follicular lesion of undetermined significance” of the Bethesda System for Reporting Thyroid Cytopathology using subcategorization and BRAF mutation results [J]. Cancer Cytopathol,2014,122 (5):368-376. HYEON J,AHN S,SHIN J H,et al. The Prediction of malignant risk in the category “atypia of undetermined significance/follicular lesion of undetermined significance” of the Bethesda System for Reporting Thyroid Cytopathology using subcategorization and BRAF mutation results [J]. Cancer Cytopathol,2014,122 (5):368-376.
4、 CIBAS E S,ALI S Z. The 2017 Bethesda system for reporting thyroid cytopathology [J]. J Am Soc Cytopathol,2017,6 (6):217- 222. CIBAS E S,ALI S Z. The 2017 Bethesda system for reporting thyroid cytopathology [J]. J Am Soc Cytopathol,2017,6 (6):217- 222.
5、 刘红刚,刘东戈,余小蒙,等. 甲状腺细胞病理学Bethesda报告系统:定义、标准和注释[M].2版.北京:北京科学技术出版社,2020:8. 刘红刚,刘东戈,余小蒙,等. 甲状腺细胞病理学Bethesda报告系统:定义、标准和注释[M].2版.北京:北京科学技术出版社,2020:8.
6、 车娜,孙保存,刘增辉,等. 1241例甲状腺结节US-FNAB病例临床特点与病理结果分析[J]. 中国肿瘤临床,2018, 45(7):350-354. 车娜,孙保存,刘增辉,等. 1241例甲状腺结节US-FNAB病例临床特点与病理结果分析[J]. 中国肿瘤临床,2018, 45(7):350-354.
7、 孙大菊,张文杰,闻春艳. 10800例甲状腺细针穿刺细胞学病理诊断分析[J]. 中国实验病理学,2015, 19(11):1916-1917. 孙大菊,张文杰,闻春艳. 10800例甲状腺细针穿刺细胞学病理诊断分析[J]. 中国实验病理学,2015, 19(11):1916-1917.
8、 ALSHAIKH S,HARB Z,ALJUFAIRI E,et al. Classification of thyroid fine-needle aspiration cytology into Bethesda categories: an institutional experience and review of the literature [J]. Cytojournal,2018, 16(15):4. ALSHAIKH S,HARB Z,ALJUFAIRI E,et al. Classification of thyroid fine-needle aspiration cytology into Bethesda categories: an institutional experience and review of the literature [J]. Cytojournal,2018, 16(15):4.
9、 林建龙,钟国栋,王鸿程,等. 2386例甲状腺细针穿刺液基细胞学病理诊断分析[J]. 诊断病理学杂志,2018, 25(2):112-117. 林建龙,钟国栋,王鸿程,等. 2386例甲状腺细针穿刺液基细胞学病理诊断分析[J]. 诊断病理学杂志,2018, 25(2):112-117.
10、 UGURLUOGLU C,DOBUR F,KARABAGLI P,et al. Fine needle aspiration biopsy of thyroid nodules: cytologic and histopathologic correlation of 1096 patients [J]. Int J Clin Exp Pathol,2015,8 (11):14800-14805. UGURLUOGLU C,DOBUR F,KARABAGLI P,et al. Fine needle aspiration biopsy of thyroid nodules: cytologic and histopathologic correlation of 1096 patients [J]. Int J Clin Exp Pathol,2015,8 (11):14800-14805.
11、 刘军,余小蒙,彭继英,等. 超声引导下甲状腺细针穿刺活检992例的临床与病理分析 [J]. 广东医学,2017, 38(4):588-591. 刘军,余小蒙,彭继英,等. 超声引导下甲状腺细针穿刺活检992例的临床与病理分析 [J]. 广东医学,2017, 38(4):588-591.
12、 孟媛,肖雨. 甲状腺细针穿刺“意义不能明确结节”恶性风险度研究进展[J]. 广东医学,2020, 41(13):1395-1398. 孟媛,肖雨. 甲状腺细针穿刺“意义不能明确结节”恶性风险度研究进展[J]. 广东医学,2020, 41(13):1395-1398.